Key result
Epicardial ICDs in infants and toddlers yield 100% survival, with ~20% receiving appropriate shocks.
Why the study?
Limited data exist regarding implantable cardioverter defibrillator usage in infants and toddlers.
Cohort (n=15)
No
Epicardial ICDs can be safely and effectively placed in infants and toddlers ≤3 years old for sudden death prevention, yielding good midterm outcomes with appropriate shocks delivered in 20% of patients and no inappropriate shocks.
No takes yet. Share an insight, caveat, or question.
Adds limited descriptive data on ICD use in infants and toddlers; leaves open optimal strategies pending prospective studies.
A 2022 study conducted a cohort in Ventricular arrhythmias or high risk of sudden cardiac death (n=15). Implantable cardioverter defibrillator (ICD) was evaluated on Appropriate shocks for ventricular tachycardia/VF. Epicardial implantable cardioverter defibrillators in infants and toddlers provided effective sudden death prevention, with 20% receiving appropriate shocks and 100% survival over 4.28 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: